← SynDRA
PX-478
SynDRA canonical compound SYN1954306 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | HIF1A |
|---|
| Mechanism of action | hypoxia inducible factor inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- hypoxia inducible factor inhibitor
- HIF1A INHIBITOR
Cross-references
Synonyms
- PX 478
- PX-478 2HCl
- UNII-T23U22X160
- PX478
- Melphalan N-Oxide Impurity HCl
- T23U22X160
- 4-[Bis(2-chloroethyl)oxidoamino]-L-phenylalanine
- PX-478 dihydrochloride
- SCHEMBL18548830
- C13H18Cl2N2O3.2ClH
- DTXSID00218688
- MolPort-035-789-733
- 2675AH
- s7612
- 2-Amino-3-(4'-N,N-bis(2-chloroethyl)amino)phenylpropionic acid N-oxide
- AKOS030231369
- CS-5164
- HY-10231
- KB-80169
- Z-3209
- L-Phenylalanine, 4-(bis(2-chloroethyl)oxidoamino)-, dihydrochloride
- (S)-4-(2-amino-2-carboxyethyl)-N,N-bis(2-chloroethyl)aniline oxide di
Look up PX-478 in the interactive SynDRA portal →